ArticleCancer chemotherapy and pharmacology2019

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Hirotoshi Iihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.